Alnylam Pharmaceuticals admitted defeat, for now, in a lawsuit in Delaware federal court that accused Moderna's blockbuster COVID-19 vaccines of infringing one of its patents.

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma ...

We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...

Fairfield and UConn researchers found that lifestyle factors like BMI, birth control and stress levels affect perceived COVID-19 vaccine symptoms.

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in ...

Startling Study Links mRNA Vaccines to Increased Asthma Risk in Children** A new study from Taiwan has raised alarm bells regarding the health risks associated with mRNA COVID-1 ...

The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

The mRNA-1273 COVID-19 booster dose was safe and elicited robust immune responses among children aged 6 months to 5 years and 6 to 11 years.

People who have been fully vaccinated against COVID-19 have a significantly lower risk of developing more severe ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

The updated formulation pertains to both approved (Comirnaty and Spikevax) and authorized (Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine) mRNA vaccines. The 2024-2025 mRNA COVID-19 ...